Chitosan and Its Structural Modifications for siRNA Delivery

被引:8
|
作者
Al-Absi, Mona Y. [1 ]
Caprifico, Anna Eleonora [1 ]
Calabrese, Gianpiero [1 ]
机构
[1] Kingston Univ London, Sch Life Sci Pharm & Chem, Penrhyn Rd, Kingston Upon Thames KT1 2EE, England
关键词
Chitosan Chitosan derivatives; siRNA Nanoparticles Gene; therapy Tumour; MOLECULAR-WEIGHT; IN-VITRO; NANOPARTICLES; LENGTH; RATIO;
D O I
10.34172/apb.2023.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The use of RNA interference mechanism and small interfering RNA (siRNA) in cancer gene therapy is a very promising approach. However, the success of gene silencing is underpinned by the efficient delivery of intact siRNA into the targeted cell. Nowadays, chitosan is one of the most widely studied non-viral vectors for siRNA delivery, since it is a biodegradable, biocompatible and positively charged polymer able to bind to the negatively charged siRNA forming nanoparticles (NPs) that will act as siRNA delivery system. However, chitosan shows several limitations such as low transfection efficiency and low solubility at physiological pH. Therefore, a variety of chemical and non-chemical structural modifications of chitosan were investigated in the attempt to develop a chitosan derivative showing the features of an ideal siRNA carrier. In this review, the most recently proposed chemical modifications of chitosan are outlined. The type of modification, chemical structure, physicochemical properties, siRNA binding affinity and complexation efficiency of the modified chitosan are discussed. Moreover, the resulting NPs characteristics, cellular uptake, serum stability, cytotoxicity and gene transfection efficiency in vitro and/or in vivo are described and compared to the unmodified chitosan. Finally, a critical analysis of a selection of modifications is included, highlighting the most promising ones for this purpose in the future.
引用
收藏
页码:275 / 282
页数:8
相关论文
共 50 条
  • [1] Chitosan and its derivatives as nanocarriers for siRNA delivery
    Al-Qadi, S.
    Grenha, A.
    Remunan-Lopez, C.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2012, 22 (01) : 29 - 42
  • [2] Structural Modifications of siRNA Improve Its Performance In Vivo
    Chernikov, Ivan V.
    Ponomareva, Ulyana A.
    Chernolovskaya, Elena L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [3] Chitosan/siRNA Nanoparticles Encapsulated in PLGA Nanofibers for siRNA Delivery
    Chen, Menglin
    Gao, Shan
    Dong, Mingdong
    Song, Jie
    Yang, Chuanxu
    Howard, Kenneth Alan
    Kjems, Jorgen
    Besenbacher, Flemming
    ACS NANO, 2012, 6 (06) : 4835 - 4844
  • [4] Development and characterisation of chitosan nanoparticles for siRNA delivery
    Katas, Haliza
    Alpar, H. Oya
    JOURNAL OF CONTROLLED RELEASE, 2006, 115 (02) : 216 - 225
  • [5] Chitosan-based siRNA delivery systems
    Ragelle, Heloise
    Vandermeulen, Gaelle
    Preat, Veronique
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) : 207 - 218
  • [6] Oligoarginine-modified chitosan for siRNA delivery
    Park, Soyeon
    Lee, Sang Kyung
    Lee, Kuen Yong
    JOURNAL OF CONTROLLED RELEASE, 2011, 152 : E165 - E166
  • [7] Advances in structural-guided modifications of siRNA
    Li, Qiang
    Dong, Mingxin
    Chen, Pu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 110
  • [8] Chitosan-Based Hybrid Nanocomplex for siRNA Delivery and Its Application for Cancer Therapy
    Min-Hyo Ki
    Ji-Eon Kim
    Young-Nam Lee
    Sang Myoung Noh
    Sung-Won An
    Hyun-Jong Cho
    Dae-Duk Kim
    Pharmaceutical Research, 2014, 31 : 3323 - 3334
  • [9] Chitosan-Based Hybrid Nanocomplex for siRNA Delivery and Its Application for Cancer Therapy
    Ki, Min-Hyo
    Kim, Ji-Eon
    Lee, Young-Nam
    Noh, Sang Myoung
    An, Sung-Won
    Cho, Hyun-Jong
    Kim, Dae-Duk
    PHARMACEUTICAL RESEARCH, 2014, 31 (12) : 3323 - 3334
  • [10] Solid lipid and chitosan particulate systems for delivery of siRNA
    Senel, B.
    Buyukkoroglu, G.
    Yazan, Y.
    PHARMAZIE, 2015, 70 (11): : 698 - 705